Gilead Sciences Inc

Founded in 1987 Gilead Sciences is one of the leaders in the discovery and development of a new class of human therapeutics based on nucleotides the building blocks of DNA and RNA in the United States The company discovers develops and commercializes medications to advance the care of patients suffering from lifethreatening diseases Headquartered in Foster City Calif it serves North America Europe and Australia and employs a staff of more than 3400 individuals Gilead Sciences areas of focus include antivirals such as HIVAIDS and chronic hepatitis as well as cardiovascular conditions including pulmonary arterial hypertension and resistant hypertension The company also conducts studies on various respiratory diseases such as influenza and cystic fibrosis

Gilead Sciences Inc is a global leader in the discovery and development of nucleotide-based human therapeutics, founded in 1987 in the United States. The company discovers, develops, and commercializes medications designed to advance care for patients with life-threatening diseases. As a professional consulting-focused business listing, Gilead supports expertise and engagement around complex healthcare innovation topics, reflecting its long-standing commitment to translating science into therapies. Gilead’s core areas of focus include antivirals for conditions such as HIV/AIDS and chronic hepatitis, as well as cardiovascular treatments for pulmonary arterial hypertension and resistant hypertension. The company also conducts studies related to respiratory diseases, including influenza and cystic fibrosis. Headquartered in Foster City, California, Gilead serves North America, Europe, and Australia, with a team of more than 3,400 employees. In the global business context on infoyeah.com, Gilead Sciences Inc is recognized for its dedicated work in advancing nucleotide-driven therapeutic development across multiple high-impact disease areas.